CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	5 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Cash Flows from Operating Activities
Net loss	$ (198,440)	$ (341,111)
Adjustments to reconcile net loss to cash used in operating activities:
Interest earned on securities held in Trust Account		(1,512,777)
Changes in operating assets and liabilities:
Prepaid expenses		(183,054)
Deferred offering costs associated with proposed public offering	(316,795)	715,444
Accounts payable to related party and accrued expenses	515,235	(276,235)
Net cash used in operating activities		(1,597,733)
Cash Flows from Investing Activities
Investments of cash in Trust Account		(236,900,000)
Net cash used in investing activities		(236,900,000)
Cash Flows from Financing Activities
Proceeds from sale of units and underwriter discounts		230,000,000
Proceeds from sale of Private Placement Warrants		14,100,000
Payment of offering costs		(5,076,288)
Net cash provided by financing activities		239,023,712
Net change in cash		525,979
Cash - beginning of the period	26,000	26,000
Cash - end of the period	26,000	551,979
Supplemental disclosure of noncash financing activities:
Deferred offering cost in deferred underwriting compensation		$ 8,050,000
Deferred offering costs in accrued expenses	$ 577,873